FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

7636111000001102: Noradrenaline tartrate 4mg/2ml solution for injection ampoules (Abbott Laboratories Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
20539101000001113 Noradrenaline tartrate 4mg/2ml solution for injection ampoules (Abbott Laboratories Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
106092601000001118 Noradrenaline (base) 2mg/2ml solution for infusion ampoules (Pfizer Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Noradrenaline tartrate 4mg/2ml solution for injection ampoules (Abbott Laboratories Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Noradrenaline tartrate 4mg/2ml solution for injection ampoules (Abbott Laboratories Ltd) Is a Norepinephrine acid tartrate 2mg/mL infusion concentrate 2mL ampule false Inferred relationship Existential restriction modifier
Noradrenaline tartrate 4mg/2ml solution for injection ampoules (Abbott Laboratories Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction hospital only true Inferred relationship Existential restriction modifier
Noradrenaline tartrate 4mg/2ml solution for injection ampoules (Abbott Laboratories Ltd) Has excipient Sodium metabisulfite false Inferred relationship Existential restriction modifier
Noradrenaline tartrate 4mg/2ml solution for injection ampoules (Abbott Laboratories Ltd) Has active ingredient Norepinephrine true Inferred relationship Existential restriction modifier
Noradrenaline tartrate 4mg/2ml solution for injection ampoules (Abbott Laboratories Ltd) Has active ingredient Norepinephrine bitartrate false Inferred relationship Existential restriction modifier
Noradrenaline tartrate 4mg/2ml solution for injection ampoules (Abbott Laboratories Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Noradrenaline tartrate 4mg/2ml solution for injection ampoules (Abbott Laboratories Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Noradrenaline tartrate 4mg/2ml solution for injection ampoules (Abbott Laboratories Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Noradrenaline tartrate 4mg/2ml solution for injection ampoules (Abbott Laboratories Ltd) Has manufactured dose form Conventional release solution for injection false Inferred relationship Existential restriction modifier
Noradrenaline tartrate 4mg/2ml solution for injection ampoules (Abbott Laboratories Ltd) Has specific active ingredient Norepinephrine bitartrate true Inferred relationship Existential restriction modifier
Noradrenaline tartrate 4mg/2ml solution for injection ampoules (Abbott Laboratories Ltd) Has dispensed dose form Conventional release solution for infusion true Inferred relationship Existential restriction modifier
Noradrenaline tartrate 4mg/2ml solution for injection ampoules (Abbott Laboratories Ltd) Has manufactured dose form Injection false Inferred relationship Existential restriction modifier
Noradrenaline tartrate 4mg/2ml solution for injection ampoules (Abbott Laboratories Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Noradrenaline tartrate 4mg/2ml solution for injection ampoules (Abbott Laboratories Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Norepinephrine true Inferred relationship Existential restriction modifier
Noradrenaline tartrate 4mg/2ml solution for injection ampoules (Abbott Laboratories Ltd) Has basis of strength substance Norepinephrine true Inferred relationship Existential restriction modifier
Noradrenaline tartrate 4mg/2ml solution for injection ampoules (Abbott Laboratories Ltd) Is a Noradrenaline (base) 2mg/2ml solution for infusion ampoules false Inferred relationship Existential restriction modifier
Noradrenaline tartrate 4mg/2ml solution for injection ampoules (Abbott Laboratories Ltd) Is a Noradrenaline (base) 2mg/2ml solution for infusion ampoules true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Noradrenaline tartrate 4mg/2ml solution for injection ampoules (Abbott Laboratories Ltd) 6 ampoule Is pack of False Noradrenaline tartrate 4mg/2ml solution for injection ampoules (Abbott Laboratories Ltd) Inferred relationship Existential restriction modifier
Noradrenaline tartrate 4mg/2ml solution for injection ampoules (Abbott Laboratories Ltd) 6 ampoule Has AMP True Noradrenaline tartrate 4mg/2ml solution for injection ampoules (Abbott Laboratories Ltd) Inferred relationship Existential restriction modifier
Noradrenaline (base) 2mg/2ml solution for infusion ampoules (Hospira UK Ltd) 5 ampoule Has AMP True Noradrenaline tartrate 4mg/2ml solution for injection ampoules (Abbott Laboratories Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start